- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Refractory B-cell Acute Lymphoblastic Leukemia in France
Total 440 results
-
Hoffmann-La RocheActive, not recruitingNeuroblastoma | Solid Tumors | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL)France, United States, Spain, Canada, United Kingdom, Netherlands
-
TakedaActive, not recruitingPediatric Philadelphia Chromosome-positive Acute Lymphoblastic Leukemia (Ph+ALL) | Ph+ Mixed Phenotype Acute Leukemia (MPAL) | Philadelphia Chromosome-Like ALL (Ph-like ALL)United States, France, Korea, Republic of, China, Spain, United Kingdom, Czechia, Portugal, Brazil, Argentina, Italy, Australia, Mexico, Netherlands, Poland
-
Hospices Civils de LyonUnknownAcute Lymphocytic LeukemiaFrance
-
Assistance Publique - Hôpitaux de ParisCompletedAcute Lymphocytic LeukemiaFrance
-
University Hospital, LilleAssistance Publique - Hôpitaux de Paris; Hospices Civils de Lyon; Central Hospital... and other collaboratorsCompletedAcute Lymphoid Leukemia Relapse | Acute Lymphoid Leukemia Relapse After Bone Marrow TransplantFrance
-
PfizerUCB PharmaCompletedAcute Lymphoblastic LeukemiaUnited States, Canada, France, Spain, China, United Kingdom, Australia, Taiwan, Singapore, Korea, Republic of, Japan, Germany, Czechia, Poland, Italy, Netherlands, Argentina, Finland, Hungary, Sweden
-
Therapeutic Advances in Childhood Leukemia ConsortiumTakeda; Children's Hospital Los AngelesActive, not recruitingLymphoblastic Leukemia, Acute, Childhood | ALL, Childhood | Lymphoblastic Lymphoma, ChildhoodUnited States, Australia
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
PfizerRecruitingACUTE LYMPHOBLASTIC LEUKEMIAItaly, Spain, Belgium, Germany, Hungary, Switzerland, Norway, Austria, France, Czechia, Finland, Netherlands, Sweden, Israel, Poland, Greece, Denmark, Slovakia
-
AbbVieRoche-GenentechCompletedNon-Hodgkin's Lymphoma | Neuroblastoma | Acute Myeloid Leukemia (AML) | Acute Lymphoblastic Leukemia (ALL) | MalignanciesUnited States, Australia, Canada, France, Germany, Netherlands, Switzerland, United Kingdom
-
French Innovative Leukemia OrganisationJanssen, LPActive, not recruitingRelapsed or Refractory Chronic Lymphocytic LeukemiaFrance
-
TakedaActive, not recruitingPhiladelphia Chromosome Positive Acute Lymphoblastic Leukemia (Ph+ALL)United States, China, Spain, Australia, Canada, Argentina, Korea, Republic of, Brazil, Japan, Italy, Mexico, France, Greece, Poland, Russian Federation, Austria, Taiwan, Bulgaria, Finland, Turkey
-
Goethe UniversityCompletedPhiladelphia Chromsome Positive Acute Lymphoblastic LeukemiaSpain, Germany, France
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Australia, Canada
-
Advesya SASNot yet recruitingAcute Myeloid Leukemia, in Relapse | Acute Myeloid Leukemia RefractoryFrance, Sweden, Spain, Germany
-
Bristol-Myers SquibbCompletedChronic Myeloid Leukemia | Leukemia, Lymphoblastic, Acute, Philadelphia-positiveNetherlands, United States, Italy, Argentina, Austria, Brazil, Canada, Germany, Peru, United Kingdom, France, Korea, Republic of, Sweden, Finland, Australia, Israel, Belgium, Denmark, Norway, Switzerland
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedRecurrent Adult Acute Lymphoblastic Leukemia | Recurrent Adult Non-Hodgkin Lymphoma | Recurrent Childhood Acute Lymphoblastic Leukemia | Recurrent Childhood Non-Hodgkin LymphomaUnited States, Canada, Puerto Rico, Australia, Switzerland
-
Children's Oncology GroupActive, not recruitingLymphoblastic Lymphoma | Acute Leukemia | Recurrent Disease | T-cell Lymphoma | Leukemia, Lymphocytic | T-cell LeukemiaUnited States
-
National Cancer Institute (NCI)SuspendedDown Syndrome | Recurrent B Acute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia
-
Novartis PharmaceuticalsCompletedAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Philadelphia Positive Chronic Myeloid LeukemiaUnited States, Germany, United Kingdom, France, Italy
-
Therapeutic Advances in Childhood Leukemia ConsortiumPfizerCompletedLymphoblastic Lymphoma | Peripheral T-cell Lymphoma | Lymphoblastic Leukemia, Acute, ChildhoodUnited States, Canada, Australia
-
French Innovative Leukemia OrganisationCompletedB Cell Chronic Lymphocytic LeukemiaFrance
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Canada, Australia, Switzerland, New Zealand
-
GenmabRecruitingAcute Myeloid Leukemia (AML) | Diffuse Large B Cell Lymphoma (DLBCL) | Relapsed or Refractory Multiple Myeloma (RRMM)United States, Korea, Republic of, Netherlands, Denmark, Australia, New Zealand, Poland, Spain, Sweden, Czechia, Malaysia, Greece, Moldova, Republic of, Georgia, Ukraine, France, Hungary, North Macedonia, Bosnia and Herzegovina and more
-
Jazz PharmaceuticalsTerminatedAcute Lymphoblastic Leukemia | Lymphoblastic LymphomaUnited States
-
Jazz PharmaceuticalsChildren's Oncology Group (COG)CompletedAcute Lymphoblastic Leukemia | Lymphoblastic LeukemiaUnited States, Canada
-
Syndax PharmaceuticalsRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | Acute Leukemia of Ambiguous Lineage | Mixed Phenotype Acute Leukemia | Mixed Lineage Acute LeukemiaUnited States, Israel, Spain, Australia, Netherlands, Germany, Canada, France, Italy, Lithuania
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedAcute Lymphoblastic LeukemiaUnited States, Canada, Puerto Rico, Australia, New Zealand, Switzerland, Ireland
-
Children's Oncology GroupNational Cancer Institute (NCI)Active, not recruitingAcute Lymphoblastic LeukemiaUnited States, Puerto Rico
-
National Cancer Institute (NCI)RecruitingDown Syndrome | B Acute Lymphoblastic Leukemia | B Lymphoblastic LymphomaUnited States, Canada, Puerto Rico, Australia, New Zealand
-
Incyte CorporationChildren's Oncology GroupActive, not recruitingLeukemiaUnited States, Canada, Puerto Rico
-
National Cancer Institute (NCI)Southwest Oncology GroupCompletedLymphoma | LeukemiaUnited States
-
Genzyme, a Sanofi CompanyBayer Healthcare Pharmaceuticals, Inc./Bayer Schering PharmaCompletedB-Cell Chronic Lymphocytic Leukemia (B-CLL)United Kingdom, Belgium, France, United States, Czech Republic, Serbia
-
University Hospital, ToulouseRecruitingRelapsed or Refractory Acute Myeloid LeukemiaFrance
-
Assistance Publique - Hôpitaux de ParisRecruitingAcute Myeloid Leukemia | Acute Lymphoblastic Leukemia | High-risk Myelodysplastic Syndrome | Myeloproliferative Neoplasm, Unclassifiable | Secondary Myelofibrosis in Myeloproliferative DiseaseFrance
-
Rennes University HospitalNovartis; Ministry of Health, FranceCompletedAcute Lymphoblastic Leukemia | Philadelphia ChromosomeFrance
-
The Lymphoma Academic Research OrganisationActive, not recruitingRefractory Indolent Adult Non-Hodgkin Lymphoma | Refractory Mantle Cell Lymphoma | Diffuse Large B-Cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell Cell LymphomaFrance
-
Southwest Oncology GroupNational Cancer Institute (NCI)Completed
-
Novartis PharmaceuticalsCompletedAcute Lymphoblastic Leukemia | Chronic Myeloid LeukemiaNetherlands, Italy, France, United Kingdom
-
The Lymphoma Academic Research OrganisationLymphoma Study AssociationNot yet recruitingRefractory High Grade B-Cell Lymphoma | Diffuse Large B-cell Lymphoma Refractory | Refractory Transformed B-cell Non-Hodgkin Lymphoma | Refractory Primary Mediastinal Large B-Cell LymphomaFrance
-
Bristol-Myers SquibbChildren's Oncology Group; EsPhALLCompletedLeukemia, PediatricUnited States, Canada, United Kingdom, Italy, Australia, Puerto Rico
-
Eastern Cooperative Oncology GroupNational Cancer Institute (NCI)CompletedLeukemiaUnited States, Puerto Rico, South Africa
-
National Cancer Institute (NCI)CompletedExtranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue | Nodal Marginal Zone B-cell Lymphoma | Recurrent Adult Burkitt Lymphoma | Recurrent Adult Diffuse Large Cell Lymphoma | Recurrent Adult Diffuse Mixed Cell Lymphoma | Recurrent Adult Diffuse Small Cleaved Cell Lymphoma and other conditionsUnited States
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
CelgeneCompletedRelapsed or Refractory Chronic Lymphocytic LeukemiaUnited States, Canada, United Kingdom, France, Germany, Spain, Italy, Sweden
-
Assistance Publique - Hôpitaux de ParisCompleted
-
Children's Oncology GroupNational Cancer Institute (NCI)Completed
-
Bristol-Myers SquibbPfizerCompletedLymphoma | Acute Lymphoblastic LeukemiaUnited States, Canada, Mexico, Belgium, Russian Federation, Hungary, Korea, Republic of, Australia, Puerto Rico, Czechia, New Zealand, Poland
-
Assistance Publique - Hôpitaux de ParisNot yet recruiting
-
Gilead SciencesCompletedRelapsed/Refractory B-cell MalignanciesFrance, United Kingdom